Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2026-02-25 @ 3:14 AM
Study NCT ID:
NCT00442312
Status:
UNKNOWN
Last Update Posted:
2007-03-01
First Post:
2007-02-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy
Sponsor:
Genovate Biotechnology Co., Ltd.,
Organization: